Titre : | Addiction, Vol.109, n°1 - January 2014 |
Type de document : | Bulletin : Périodique |
Paru le : | 01/01/2014 |
Année de publication : | 2014 |
Format : | 1-172 |
Langues: | Anglais |
Note de contenu : |
CONTENTS:
- Should public health bodies stop commissioning research from market research companies that serve the tobacco industry? [Editorial]. Brown J., Michie S., Raupach T., West R., p. 1-2. - Is research in substance abuse undervalued? [Editorial]. Sindelar J.L., Strombotne K.L., p. 3-4. - Addiction research centres and the nurturing of creativity: The Kurihama Medical and Addiction Centre - a profile. Tohyama T., Yokoyama A., Matsushita S., Higuchi S., p. 5-11. - Conversation with Connie Weisner. 12-19. - Retention of participants in medication-assisted programs in low- and middle-income countries: an international systematic review. Feelemyer J., Des Jarlais D., Arasteh K., Abdul-Quader A.S., Hagan H., p. 20-32. - Commentary on Freelemyer et al. (2014): Medication-assisted treatment in Africa - need is growing but response remains tepid. Obot I.S., p. 33-34. - A systematic review of studies assessing the association between adherence to smoking cessation medication and treatment success. Raupach T., Brown J., Herbec A., Brose L., West R., p. 35-43. - Acute alcohol-related dysfunction as a predictor of employment status in a longitudinal study of working-age men in Izhevsk, Russia. Cook S., DeStavola B.L., Saburova L., Leon D.A., p. 44-54. - Legalization of Sunday alcohol sales and alcohol consumption in the United States. Yörük B.K., p. 55-61. - Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems. Fuster D., Cheng D.M., Quinn E.K., Nunes D., Saitz R., Samet J.H., et al., p. 62-70. - Usefulness of indirect alcohol biomarkers for predicting recidivism of drunk-driving among previously convicted drunk-driving offenders: results from the Recidivism Of Alcohol-impaired Driving (ROAD) study. Maenhout T.M., Poll A., Vermassen T., De Buyzere M.L., Delanghe J.R., the R.S.G., p. 71-78. - Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial. Hser Y.-I., Saxon A.J., Huang D., Hasson A., Thomas C., Hillhouse M., et al., p. 79-87. - Commentary on Hser et al. (2014): To retain or not to retain - open questions in opioid maintenance therapy. Soyka M., Hillemacher T., p. 88-89. - Causes of death in a cohort treated for opioid dependence between 1985 and 2005. Degenhardt L., Larney S., Randall D., Burns L., Hall W., p. 90-99. - Commentary on Degenhardt et al. (2014): Cohort studies enhance the picture of drug-related deaths. Fugelstad A., p. 100-101. - Non-medical use of prescription opioids during the transition to adulthood: a multi-cohort national longitudinal study. McCabe S.E., Schulenberg J.E., O'Malley P.M., Patrick M.E., Kloska D.D., p. 102-110. - The relationship between cannabis outcome expectancies and cannabis refusal self-efficacy in a treatment population. Connor J.P., Gullo M.J., Feeney G.F.X., Kavanagh D.J., Young R.M., p. 111-119. - A closer look at the evidence for sex differences in the genetic and environmental influences on gambling in the National Longitudinal Study of Adolescent health: from disordered to ordered gambling. Slutske W.S., Richmond-Rakerd L.S., p. 120-127. - Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6). Chen L.-S., Bloom A.J., Baker T.B., Smith S.S., Piper M.E., Martinez M., et al., p. 128-137. - Commentary on Chen et al. (2014): Another step on the road to clinical utility of pharmacogenetics for smoking cessation? David S.P., p. 138-139. - Impact of the 2009 Taiwan Tobacco Hazards Prevention Act on smoking cessation. Chang F.-C., Sung H.-Y., Zhu S.-H., Chiou S.-T., p. 140-146. - Did hardening occur among smokers in England from 2000 to 2010? Docherty G., McNeill A., Gartner C., Szatkowski L., p. 147-154. - Tobacco use disorder and the risk of suicide mortality. Bohnert K.M., Ilgen M.A., McCarthy J.F., Ignacio R.V., Blow F.C., Katz I.R., p. 155-162. - A second-class science? A defence of observational epidemiology to make causal inferences. Bell S., Britton A., p. 163-164. - Second-class evidence for causality, not second-class science. Fekjaer H.O., p. 164-165. |
Cote : | Abonnement |
Lien : | http://onlinelibrary.wiley.com/doi/10.1111/add.2014.109.issue-1/issuetoc |
Dépouillements
Ajouter le résultat dans votre panierArticle : Périodique
Y. I. HSER ;
A. J. SAXON ;
D. HUANG ;
A. HASSON ;
C. THOMAS ;
M. HILLHOUSE ;
P. JACOBS ;
C. TERUYA ;
P. McLAUGHLIN ;
K. WIEST ;
A. COHEN ;
W. LING
|
Aims: To examine patient and medication characteristics associated with retention and continued illicit opioid use in methadone (MET) versus buprenorphine/naloxone (BUP) treatment for opioid dependence.
Design, settings and participants: This s[...]
Article : Périodique
L. DEGENHARDT ;
S. LARNEY ;
D. RANDALL ;
L. BURNS ;
W. HALL
|
Aims: To examine changes in causes of death in a cohort treated for opioid dependence, across time and age; quantify years of potential life lost (YPLL); and identify avoidable causes of death.
Design: People in New South Wales (NSW) who regist[...]
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil